Antibacterial agents in clinical development (WHO, 2017). An analysis of the antibacterial clinical development pipeline, including tuberculosis.
Drug-Resistant Infections: A Threat to Our Economic Future (World Bank Group, 2017). Insights into the extent and broad patterns of the economic impacts of AMR and their implications for poverty.
Global Framework for Development and Stewardship to Combat Antimicrobial Resistance (WHO, FAO, OIE- 2017)
Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics (WHO, 2017)
Report of the WHO Expert Committee on Selection and Use of Essential Medicines (2017)
The BMJ’s collection on Antimicrobial resistance in South East Asia. A series of 15 articles highlighting how antimicrobial resistance (AMR) has become a critical political, social, and economic problem in the WHO South East Asia region (BMJ, 2017)
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015 (ECDC and EFSA, 2017)
Second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals (ECDC/EFSA/EMA, 2017)
Antibiotic Use in the United States, 2017: Progress and Opportunities (CDC, 2017)
Central Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual report (WHO, 2016)
AMR Surveillance in low- and middle-income settings. A roadmap for participation in the global antimicrobial surveillance system (Fleming Fund, 2016)
Annual report on the use of antimicrobial agents in animals. Better understanding of the global situation (OIE, 2016)
Worldwide country situation analysis: response to antimicrobial resistance (WHO 2015)
Antimicrobial resistance surveillance in Europe (ECDC, 2015)
WHO’s report on the state of global antimicrobial resistance surveillance (2014)
Jim O’Neill’s Review on Antimicrobial Resistance for the UK Government. A key finding of the review is a projected 10 million deaths from antimicrobial resistant infections by 2050. Nearly 90% of those will occur in Africa and Asia. The report also highlights novel incentives that could be used to boost the development pipeline for new antibiotics
WHO’s Global Action Plan on Antimicrobial Resistance
UK Five Year Antimicrobial Resistance Strategy 2013 to 2018
The State of the World’s Antibiotics 2015. A report from the Centre for Disease Dynamics, Economics and Policy
Towards a New Global Model for Antibiotics. A report from the Centre on Global Health Security at Chatham House
Exploring the Consumer Perspective on Antimicrobial Resistance. Findings from a Wellcome Trust-commissioned study on the public’s understanding of and attitudes towards antibiotics and antimicrobials. Highlights some key challenges in public communication of antimicrobial resistance and makes useful recommendations
OECD Report: On Antimicrobial Resistance in G7 countries and beyond : Economic Issues, Policies and Options for Action
Impacts of antimicrobial growth promoter termination in Denmark. The WHO international review panel’s evaluation of the termination of the use of antimicrobial growth promoters in Denmark